Product Information
- UNII-IV344R972X
- Edoxaban 4-Carboxylic Acid
- D21-2393
- D21 2393
D21-2393 subjects received a single-oral-dose of edoxaban 30-90 mg in each study occasion under fasting condition. Serial blood samples were collected to measure the plasma concentrations of edoxaban and its major active metabolite D21-2393. Meanwhile, PT, INR, aPTT were measured pre- and post-dose.
Chemical properties
Technical inquiry about: TM-T19873 Edoxaban M4
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.